{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:00:54Z","timestamp":1788804054819,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1002\/jps.24647","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T17:42:41Z","timestamp":1442425361000},"page":"687-696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Gastrointestinal Behavior of Weakly Acidic BCS Class II Drugs in Man\u2014Case Study of Diclofenac Potassium"],"prefix":"10.1016","volume":"105","author":[{"given":"Jens","family":"Van Den Abeele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Mattheus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1002\/jps.24647_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1002\/jps.24647_bib2","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1124\/dmd.113.054031","article-title":"A\u00a0perspective on the prediction of drug pharmacokinetics and disposition in drug research and development","volume":"41","author":"Di","year":"2013","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1002\/jps.24647_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","article-title":"The price of innovation: New estimates of drug development costs","volume":"22","author":"DiMasi","year":"2003","journal-title":"J\u00a0Health Econ"},{"issue":"2","key":"10.1002\/jps.24647_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1377\/hlthaff.25.2.420","article-title":"Estimating the cost of new drug development: Is it really 802 million dollars?","volume":"25","author":"Adams","year":"2006","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"10.1002\/jps.24647_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: The pharmaceutical industry's grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1002\/jps.24647_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40290-015-0090-x","article-title":"Big data in pharmaceutical R&D: Creating a sustainable R&D engine","volume":"29","author":"Tormay","year":"2015","journal-title":"Pharm Med"},{"key":"10.1002\/jps.24647_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejps.2013.08.024","article-title":"In\u00a0vitro models for the prediction of in\u00a0vivo performance of oral dosage forms","volume":"57","author":"Kostewicz","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.24647_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejps.2014.01.010","article-title":"Resolving intraluminal drug and formulation behavior: Gastrointestinal concentration profiling in humans","volume":"61","author":"Brouwers","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1002\/jps.24647_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/mp5006036","article-title":"Mechanism for enhanced absorption of a solid dispersion formulation of LY2300559 using the artificial stomach duodenum model","volume":"12","author":"Polster","year":"2015","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1002\/jps.24647_bib10","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s11095-013-0974-y","article-title":"Design of biorelevant test setups for the prediction of diclofenac in\u00a0vivo features after oral administration","volume":"30","author":"Guhmann","year":"2013","journal-title":"Pharm Res"},{"issue":"11","key":"10.1002\/jps.24647_bib11","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1002\/jps.22669","article-title":"Effect of gastric pH on the pharmacokinetics of a BCS class II compound in dogs: Utilization of an artificial stomach and duodenum dissolution model and GastroPlus, simulations to predict absorption","volume":"100","author":"Bhattachar","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"issue":"11","key":"10.1002\/jps.24647_bib12","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1002\/jps.23690","article-title":"Gastric pre-processing is an important determinant of the ability of medium-chain lipid solution formulations to enhance oral bioavailability in rats","volume":"102","author":"Lee","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"4-5","key":"10.1002\/jps.24647_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2008.01.014","article-title":"In\u00a0vitro methods can forecast the effects of intragastric residence on dosage form performance","volume":"33","author":"Kalantzi","year":"2008","journal-title":"Eur J Pharm Sci"},{"issue":"1-2","key":"10.1002\/jps.24647_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijpharm.2014.03.031","article-title":"Application of the Dynamic Gastric Model to evaluate the effect of food on the drug release characteristics of a hydrophilic matrix formulation","volume":"466","author":"Chessa","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.24647_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejps.2013.09.004","article-title":"Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach","volume":"57","author":"Koziolek","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1002\/jps.24647_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1208\/s12249-013-0050-2","article-title":"Release characteristics of quetiapine fumarate extended release tablets under biorelevant stress test conditions","volume":"15","author":"Garbacz","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"10.1002\/jps.24647_bib17","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/jps.21650","article-title":"Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?","volume":"98","author":"Brouwers","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"issue":"12","key":"10.1002\/jps.24647_bib18","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s11095-011-0506-6","article-title":"Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults","volume":"28","author":"Psachoulias","year":"2011","journal-title":"Pharm Res"},{"key":"10.1002\/jps.24647_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2015.01.001","article-title":"Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: in\u00a0vitro, rat in situ and human in\u00a0vivo studies","volume":"90","author":"Stappaerts","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1002\/jps.24647_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejpb.2012.01.017","article-title":"Supersaturation in human gastric fluids","volume":"81","author":"Bevernage","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1002\/jps.24647_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jphp.12320","article-title":"Identification of key factors affecting the oral absorption of salts of lipophilic weak acids: A case example","volume":"67","author":"Petrakis","year":"2015","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1002\/jps.24647_bib22","article-title":"The BCS: Where do we go from here?","volume":"5","author":"Dressman","year":"2001","journal-title":"Pharm Technol"},{"issue":"6","key":"10.1002\/jps.24647_bib23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/jps.20064","article-title":"Summary workshop report: biopharmaceutics classification system\u2014Implementation challenges and extension opportunities","volume":"93","author":"Polli","year":"2004","journal-title":"J\u00a0Pharm Sci"},{"issue":"7","key":"10.1002\/jps.24647_bib24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1023\/A:1016473601633","article-title":"Biopharmaceutics classification system: the scientific basis for biowaiver extensions","volume":"19","author":"Yu","year":"2002","journal-title":"Pharm Res"},{"issue":"1","key":"10.1002\/jps.24647_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0975-8453.59514","article-title":"Biopharmaceutics classification system","volume":"1","author":"Chavda","year":"2010","journal-title":"Sys Rev Pharm"},{"key":"10.1002\/jps.24647_bib26","unstructured":"(CDER) FaDA. 2015. Waiver of in\u00a0vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system - Guidance for industry. FDA. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm070246.pdf. Accessed on July 7,\u00a02015."},{"key":"10.1002\/jps.24647_bib27","series-title":"Guideline on the investigation of bioequivalence","author":"EMA","year":"2010"},{"issue":"7","key":"10.1002\/jps.24647_bib28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/bdd.1800","article-title":"In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: Ibuprofen and ketoprofen","volume":"33","author":"Tsume","year":"2012","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"10.1002\/jps.24647_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1208\/s12248-008-9023-x","article-title":"Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds","volume":"10","author":"Tubic-Grozdanis","year":"2008","journal-title":"AAPS J"},{"issue":"9","key":"10.1002\/jps.24647_bib30","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1023\/B:PHAM.0000041450.25106.c8","article-title":"Identification of biowaivers among Class II drugs: Theoretical justification and practical examples","volume":"21","author":"Rinaki","year":"2004","journal-title":"Pharm Res"},{"issue":"5","key":"10.1002\/jps.24647_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1211\/0022357023367","article-title":"Media to simulate the postprandial stomach I. Matching the physicochemical characteristics of standard breakfasts","volume":"56","author":"Klein","year":"2004","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"11","key":"10.1002\/jps.24647_bib32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/11592630-000000000-00000","article-title":"Effect of pH and comedication on gastrointestinal absorption of posaconazole: Monitoring of intraluminal and plasma drug concentrations","volume":"50","author":"Walravens","year":"2011","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1002\/jps.24647_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejps.2013.04.002","article-title":"Biopharmaceutical classification of poorly soluble drugs with respect to \u201cenabling formulations\u201d","volume":"50","author":"Buckley","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.24647_bib34","first-page":"117","article-title":"Phase-solubility techniques","volume":"4","author":"Higuchi","year":"1965","journal-title":"Adv Anal Chem Instrum"},{"issue":"4","key":"10.1002\/jps.24647_bib35","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/jps.21525","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: Diclofenac sodium and diclofenac potassium","volume":"98","author":"Chuasuwan","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1002\/jps.24647_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11095-005-8476-1","article-title":"Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability\/bioequivalence studies","volume":"23","author":"Kalantzi","year":"2006","journal-title":"Pharm Res"},{"issue":"3 Pt B","key":"10.1002\/jps.24647_bib37","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ejpb.2013.05.007","article-title":"Characterization of fasted human gastric fluid for relevant rheological parameters and gastric lipase activities","volume":"85","author":"Pedersen","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.24647_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejps.2014.07.008","article-title":"Gastrointestinal transfer: In\u00a0vivo evaluation and implementation in in\u00a0vitro and in silico predictive tools","volume":"63","author":"Hens","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1002\/jps.24647_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/gut.29.1.85","article-title":"Biphasic nature of gastric emptying","volume":"29","author":"Siegel","year":"1988","journal-title":"Gut"},{"issue":"11","key":"10.1002\/jps.24647_bib40","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s11695-009-9954-z","article-title":"Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects","volume":"19","author":"Braghetto","year":"2009","journal-title":"Obes Surg"},{"issue":"4","key":"10.1002\/jps.24647_bib41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1756283X12437358","article-title":"Overutilization of proton-pump inhibitors: What the clinician needs to know","volume":"5","author":"Heidelbaugh","year":"2012","journal-title":"Ther Adv Gastroenterol"},{"issue":"1","key":"10.1002\/jps.24647_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1572-0241.2003.07186.x","article-title":"Who is using chronic acid suppression therapy and why?","volume":"98","author":"Jacobson","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1002\/jps.24647_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1542\/peds.2011-2879","article-title":"Trends of outpatient prescription drug utilization in US children, 2002-2010","volume":"130","author":"Chai","year":"2012","journal-title":"Pediatrics"},{"key":"10.1002\/jps.24647_bib44","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1007\/s10620-015-3642-8","article-title":"The inappropriate prescription of oral proton pump inhibitors in the hospital setting: A prospective cross-sectional study","volume":"60","author":"Kelly","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"8","key":"10.1002\/jps.24647_bib45","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1365-2036.2000.00788.x","article-title":"Review article: Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors","volume":"14","author":"Stedman","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1002\/jps.24647_bib46","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s10620-009-1076-x","article-title":"Effects of proton pump inhibitors on gastric emptying: A systematic review","volume":"55","author":"Sanaka","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1002\/jps.24647_bib47","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/mp500022u","article-title":"Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI","volume":"11","author":"Koziolek","year":"2014","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1002\/jps.24647_bib48","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/mp500210c","article-title":"Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state","volume":"11","author":"Mudie","year":"2014","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1002\/jps.24647_bib49","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s10620-013-2665-2","article-title":"Use of a high caloric liquid meal as an alternative to a solid meal for gastric emptying scintigraphy","volume":"58","author":"Sachdeva","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1002\/jps.24647_bib50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2165\/00003088-199733030-00003","article-title":"Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls","volume":"33","author":"Davies","year":"1997","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"10.1002\/jps.24647_bib51","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.clinthera.2009.10.001","article-title":"Effects of food intake on the pharma- cokinetics of diclofenac potassium soft gelatin capsules: a single-dose, randomized, two-way crossover study","volume":"31","author":"Scallion","year":"2009","journal-title":"Clin Ther"},{"issue":"2","key":"10.1002\/jps.24647_bib52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/head.12483","article-title":"Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: Effect of fed and fasting conditions","volume":"55","author":"Chen","year":"2015","journal-title":"Headache"},{"issue":"6","key":"10.1002\/jps.24647_bib53","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jbiomech.2006.06.006","article-title":"A\u00a0stomach road or \u201cMagenstrasse\u201d for gastric emptying","volume":"40","author":"Pal","year":"2007","journal-title":"J\u00a0Biomech"},{"issue":"11","key":"10.1002\/jps.24647_bib54","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5414\/CPP38546","article-title":"Bioavailability of a new effervescent tablet of diclofenac","volume":"38","author":"Terhaag","year":"2000","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"6","key":"10.1002\/jps.24647_bib55","first-page":"333","article-title":"Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks","volume":"33","author":"Macia","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"10.1002\/jps.24647_bib56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1007574710140","article-title":"Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: Relation to pharmacodynamics in an experimental pain model","volume":"17","author":"Lotsch","year":"2000","journal-title":"Pharm Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T13:14:47Z","timestamp":1567170887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0022354915000751"],"URL":"https:\/\/doi.org\/10.1002\/jps.24647","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725994655.793521185","asserted-by":"object"}]},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal Behavior of Weakly Acidic BCS Class II Drugs in Man\u2014Case Study of Diclofenac Potassium","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/jps.24647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}